Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Indegene Ltd

NSE: INDGN · BSE: 544172 · Healthcare · 37 announcements

Share price
₹598.40
Market cap
₹14,416 Cr
Revenue (annual)
₹3,510 Cr
Net profit (annual)
₹401.1 Cr
P/E (TTM)
36.0×Sector 53.1×
Promoter holding
0.00%+0.00% QoQ
FII holding
9.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:55 IST BSE
Business Update

Indegene Business Update

Indegene Limited hosted its Indegene Digital Summit 2026, focusing on operationalizing AI within life sciences. The event also featured the presentation of the VITAL Awards 2026.

19:50 IST BSE
Merger & Restructuring

Indegene Merger & Restructuring

Indegene Limited completed the internal merger of its two indirect wholly owned subsidiaries in Germany. This reorganization does not impact Indegene's financial position or operations.

18:11 IST NSE
Legal & Regulatory

Indegene Legal & Regulatory

Indegene Limited received preliminary court approval for a class action settlement related to the U.S. Telephone Consumer Protection Act. Final hearing is scheduled for January 2027.

18:03 IST BSE
Legal & Regulatory

Indegene Legal & Regulatory

The U.S. Court preliminarily approved the class action settlement for Indegene's subsidiary. The maximum settlement fund is approximately ₹44.84 Crore.

Value
₹44.84 Cr
12:14 IST NSE
Legal & Regulatory

Indegene Legal & Regulatory

Indegene Limited's subsidiary, Indegene Inc., finalized a class-action settlement framework regarding U.S. fax communication violations. The maximum potential settlement fund is USD 4.72 million (₹44.84 Crore).

Value
₹44.84 Cr
12:04 IST NSE
Legal & Regulatory

Indegene Legal & Regulatory

Indegene Limited's subsidiary finalized a USD 4.72 million class-action settlement agreement regarding U.S. TCPA violations. The settlement, involving approximately 18,851 unique fax numbers, remains subject to court approval.

Value
₹45.24 Cr
12:17 IST NSE
Management Change

Indegene Management Change

Indegene Limited shareholders approved the appointment of Ms. Jill Mary De Simone as an Independent Director for a three-year term starting January 22, 2026.

Execution
3 years
18:55 IST BSE
Annual General Meeting

Indegene Annual General Meeting

Indegene Ltd held its 28th Annual General Meeting on August 13, 2026. The meeting transacted business including dividend declaration and appointment of directors.

11:17 IST BSE
Capital Structure Change

Indegene Capital Structure Change

BPC Genesis Fund I SPV Limited, a non-promoter entity, sold its entire 5.757% stake in Indegene Limited. The open market transaction involved 13,862,223 equity shares.